First Look Analysts Research Calls for Tuesday, January 3
This report was sent to Briefing.com subscribers earlier today. Upgrades: > Adaptimmune Therapeutics (ADAP) upgraded to Buy from Neutral at Guggenheim; tgt $5 > Edison (EIX) upgraded to Buy from Neutral at UBS; tgt raised to $75 > Enfusion (ENFN)…
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
This report was sent to Briefing.com subscribers earlier today.
Upgrades:
> Adaptimmune Therapeutics (ADAP) upgraded to Buy from Neutral at Guggenheim; tgt $5
> Edison (EIX) upgraded to Buy from Neutral at UBS; tgt raised to $75
> Enfusion (ENFN) upgraded to Overweight from Equal-Weight at Morgan Stanley; tgt lowered to $12
Downgrades:
> Ally Financial (ALLY) downgraded to Equal Weight from Overweight at Barclays; tgt lowered to $33
> American Homes 4 Rent (AMH) downgraded to Hold from Buy at Jefferies; tgt lowered to $32
> Apple (AAPL) downgraded to Neutral from Outperform at Exane BNP Paribas; tgt $140
> Azenta (AZTA) downgraded to In-line from Outperform at Evercore ISI; tgt raised to $62
> Capital One (COF) downgraded to Equal Weight from Overweight at Barclays; tgt lowered to $119
> CubeSmart (CUBE) downgraded to Hold from Buy at Jefferies; tgt lowered to $41
> Entergy (ETR) downgraded to Neutral from Buy at BofA Securities; tgt lowered to $119
> Fate Therapeutics (FATE) downgraded to Neutral from Buy at Guggenheim
> Fresenius Medical (FMS) downgraded to Underperform from Buy at Jefferies; tgt lowered to $11.70
> Traeger (COOK) downgraded to Sector Perform from Outperform at RBC Capital Mkts; tgt lowered to $3
Others:
> General Mills (GIS) initiated with an Equal Weight at Wells Fargo
> Hershey Foods (HSY) initiated with an Underweight at Wells Fargo
Contact [email protected] for any questions or corrections.